Literature DB >> 7481076

Expression of neutrophil activation markers and neutrophil adhesion to chondrocytes in rheumatoid arthritis patients: relationship with disease activity.

L S De Clerck1, C M De Gendt, C H Bridts, N Van Osselaer, W J Stevens.   

Abstract

Neutrophil infiltration in synovial fluid is an important step in inflammation characterizing rheumatoid arthritis (RA). In this study, the activation and functional state of neutrophils in the blood and synovial fluid of patients with rheumatoid arthritis were compared: mean density of neutrophil activation markers CD11b, CD18 and L-selectin was measured with a flow cytometer, and adhesion to chondrocytes using a fluorimetric assay. No significant differences between control and patient peripheral blood neutrophils were observed. When comparing neutrophils of patient peripheral blood with paired synovial fluid, an increase in CD11b (p = 0.008) and a decrease in L-selectin (p = 0.008) were measured. For neutrophils of control and patient peripheral blood, fMet-Leu-Phe stimulation induced upregulation of CD11b (resp p = 0.007 and p = 0.008) and CD18 (resp p = 0.005 and p = 0.01). In the synovial fluid, no significant increase in CD11b and CD18 could be induced with fMet-Leu-Phe. Percentages of adherent neutrophils were comparable between controls and patients, both in peripheral blood and synovial fluid. Adhesion to chondrocytes of peripheral blood neutrophils of patients was correlated with clinical (Ritchie) and biological (erythrocyte sedimentation rate) parameters (resp r = 0.67, r = 0.73). In conclusion, these results demonstrate that peripheral blood neutrophil adhesion to chondrocytes was correlated with active disease, and that synovial fluid neutrophils were activated in vivo. These findings provide further evidence for the contributing role of neutrophils in articular destruction in RA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7481076     DOI: 10.1016/0923-2494(96)80241-0

Source DB:  PubMed          Journal:  Res Immunol        ISSN: 0923-2494


  7 in total

1.  The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria.

Authors:  Purnima Ghose; Asim Q Ali; Rong Fang; Digna Forbes; Billy Ballard; Nahed Ismail
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

2.  ATF3-mediated epigenetic regulation protects against acute kidney injury.

Authors:  Hsiao-Fen Li; Ching-Feng Cheng; Wei-Ju Liao; Heng Lin; Ruey-Bing Yang
Journal:  J Am Soc Nephrol       Date:  2010-04-01       Impact factor: 10.121

3.  Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA).

Authors:  T Kasama; K Kobayashi; N Yajima; F Shiozawa; Y Yoda; H T Takeuchi; Y Mori; M Negishi; H Ide; M Adachi
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

4.  Liver transcriptome profiles associated with strain-specific Ehrlichia chaffeensis-induced hepatitis in SCID mice.

Authors:  Koshiro Miura; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2008-11-10       Impact factor: 3.441

5.  Rheumatoid peripheral blood phagocytes are primed for activation but have impaired Fc-mediated generation of reactive oxygen species.

Authors:  Anna-Marie Fairhurst; Paul K Wallace; Ali S M Jawad; Nicolas J Goulding
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

6.  A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis.

Authors:  Ryosuke Hanaoka; Tsuyoshi Kasama; Mizuho Muramatsu; Nobuyuki Yajima; Fumitaka Shiozawa; Yusuke Miwa; Masao Negishi; Hirotsugu Ide; Hideyo Miyaoka; Hitoshi Uchida; Mitsuru Adachi
Journal:  Arthritis Res Ther       Date:  2003-01-06       Impact factor: 5.156

7.  Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis.

Authors:  Paulina Chalan; Johan Bijzet; Minke G Huitema; Bart-Jan Kroesen; Elisabeth Brouwer; Annemieke M H Boots
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.